Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging

SKT Que, FO Zwald, CD Schmults - Journal of the American Academy of …, 2018 - Elsevier
Cutaneous squamous cell carcinoma (cSCC), a malignant proliferation of cutaneous
epithelium, represents 20% to 50% of skin cancers. Although the majority of cSCCs are …

Approved antiviral drugs over the past 50 years

E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …

Cancer immunotherapy: the beginning of the end of cancer?

S Farkona, EP Diamandis, IM Blasutig - BMC medicine, 2016 - Springer
These are exciting times for cancer immunotherapy. After many years of disappointing
results, the tide has finally changed and immunotherapy has become a clinically validated …

The MRE11–RAD50–NBS1 complex conducts the orchestration of damage signaling and outcomes to stress in DNA replication and repair

A Syed, JA Tainer - Annual review of biochemistry, 2018 - annualreviews.org
Genomic instability in disease and its fidelity in health depend on the DNA damage
response (DDR), regulated in part from the complex of meiotic recombination 11 homolog 1 …

Human papillomavirus molecular biology and disease association

J Doorbar, N Egawa, H Griffin… - Reviews in medical …, 2015 - Wiley Online Library
Human papillomaviruses (HPVs) have evolved over millions of years to propagate
themselves in a range of different animal species including humans. Viruses that have co …

Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer

L Zhou, Q Qiu, Q Zhou, J Li, M Yu, K Li, L Xu… - Nature …, 2022 - nature.com
Integration of human papillomavirus (HPV) DNA into the human genome is considered as a
key event in cervical carcinogenesis. Here, we perform comprehensive characterization of …

The biology and life-cycle of human papillomaviruses

J Doorbar, W Quint, L Banks, IG Bravo, M Stoler… - Vaccine, 2012 - Elsevier
Human papillomaviruses (HPVs) comprise a diverse group, and have different epithelial
tropisms and life-cycle strategies. Many HPVs are classified as low-risk, as they are only …

Landscape of genomic alterations in cervical carcinomas

AI Ojesina, L Lichtenstein, SS Freeman, CS Pedamallu… - Nature, 2014 - nature.com
Cervical cancer is responsible for 10–15% of cancer-related deaths in women worldwide,.
The aetiological role of infection with high-risk human papilloma viruses (HPVs) in cervical …

[HTML][HTML] The low-risk papillomaviruses

N Egawa, J Doorbar - Virus research, 2017 - Elsevier
Human Papillomavirus (HPV) research has been dominated by the study of a subset of
Alpha papillomaviruses that together cause almost 5% of human cancers worldwide, with …

Soluble PD-1: predictive, prognostic, and therapeutic value for cancer immunotherapy

M Khan, Z Zhao, S Arooj, Y Fu, G Liao - Frontiers in immunology, 2020 - frontiersin.org
Programmed death protein 1 (PD-1) interaction with PD-L1 deliver immunosuppressive
environment for tumor growth, and its blockade with directed monoclonal antibodies (anti …